课题基金 / 基金详情

The role of CCL2 in nephronophthisis and autosomal dominant polycystic kidney disease (ADPKD)

The role of CCL2 in nephronophthisis and autosomal dominant polycystic kidney disease (ADPKD)
CCL2 在肾结核和常染色体显性多囊肾病 (ADPKD) 中的作用
批准号:
361416317
负责人:
Professor Dr. E. Wolfgang Kühn
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2017
资助国家:
德国
项目状态:
已结题
起止时间:
2016-12-31 至 2020-12-31

项目摘要

项目成果

Professor Dr. E. Wolfgang Kühn的其他基金

相似基金

相关文献

中文摘要
翻译
肾病和常染色体显性多囊肾病(ADPKD)是导致肾衰竭的遗传性肾病的最常见形式。在肾单位病中,肾脏最常在儿童或青春期衰竭,而在ADPKD中,这发生在成年期。对于这些病症没有有效的治疗方法。在肾单位结核中,代表肾脏内部的肾髓质萎缩。这导致肾小管阻塞和气球样变,以及肾组织瘢痕形成。在ADPKD中,肾脏越来越多地获得越来越多的充满液体的囊肿,这导致肾脏生长到正常大小的几倍,并通过对周围组织的压力形成疤痕。大肾脏会导致慢性疼痛和正常进食量的问题。ADPKD是一种常见的疾病,影响约1/1000的人,另一方面,肾单位结核不太常见。在肾衰竭的情况下,受影响的人需要每周进行几次血液透析,每天进行几次腹膜透析或进行肾移植。移植需要几十年来每天服用几次药物来抑制免疫系统并防止排斥反应。在早期的工作中,我们的团队发现两种名为Lkb 1和Ccl 2的蛋白质可能在这两种疾病中发生的瘢痕形成中起重要作用。这两种疾病的共同点是突变的蛋白质在正常情况下定位于纤毛。纤毛是从细胞表面突出的毛发状结构,其作用是接收来自环境的信号并将其传递到细胞中。我们发现Lkb 1定位于纤毛内,并与肾单位结核中突变的蛋白质相互作用以抑制Ccl 2。我们还发现,在超过80%的ADPKD患者中突变的蛋白质参与抑制Ccl 2。我们认为,这种调节机制的失活导致Ccl 2将免疫细胞募集到肾脏,导致炎症、瘢痕形成,并在ADPKD中导致囊肿生长。目前的项目旨在找出是否确实如此,并希望检测哪些其他纤毛蛋白参与了这种机制的失调。从该项目获得的知识将有助于找到治疗这些疾病的新方法,并维持受影响者的肾脏功能。
英文摘要
Nephronophthisis and autosomal dominant polycystic kidney disease (ADPKD) are the most common forms of inherited kidney disease leading to kidney failure. In nephronophthisis the kidneys most often fail during childhood or adolescence, whereas in ADPKD this occurs in adulthood. No effective therapies for these conditions exist. In nephronophthisis, the renal medulla, which represents the inner part of the kidney, shrinks. This leads to obstruction and ballooning of the kidney tubules, and to scarring of kidney tissue. In ADPKD the kidneys increasingly acquire more and more fluid filled cysts which causes the kidneys to grow to several times the normal size, and to scarring through the pressure on the surrounding tissue. The large kidneys can lead to chronic pain and problems with eating normal quantities of food. ADPKD is a common disorder, affecting around 1 in 1000 persons, nephronophthisis on the other hand is less common. In the event of kidney failure affected persons need to do hemodialysis several times per week, administer peritoneal dialysis several times daily or undergo kidney transplantation. Transplantation requires that medications are taken several times daily for decades to suppress the immune system and prevent rejection. In earlier work our group has found that two proteins named Lkb1 and Ccl2 possibly play an important role in the scarring that occurs in both diseases. Both diseases have in common that the mutated proteins under normal circumstances localize in the cilium. The cilium is a hair-like structure that protrudes from the cell surface and acts to receive signals from the environment and to transduce them into the cell. We have found that Lkb1 localizes inside the cilium and interacts with a protein that is mutated in nephronophthisis to suppress Ccl2. We also find that the protein mutated in over 80% of patients with ADPKD takes part in suppressing Ccl2. We propose that inactivation of this regulation mechanism causes Ccl2 to recruit immune cells to the kidney leading to inflammation, scarring and in ADPKD to cyst growth. The current project aims to find out if this is indeed the case and wants to detect which other cilium proteins are involved in the deregulation of this mechanism. The knowledge derived from this project shall help to find new approaches to treat these diseases and maintain the function of the kidneys in affected persons.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of Hippo signaling in the pathophysiology of autosomal dominant polycystickidney disease (ADPKD)
The role of ciliary transport proteins in tubular epithelial cell polarity of three-dimensional structures
Characterization of the ciliary flow sensor and its role in epithelial cell polarity
Charakterisierung des Kidney Injury Molecule-1 Promotors
国内基金
海外基金
自噬相关基因CCl2在颅脑创伤(TBI)中通过TNF信号通路导致神经元损伤的机制研究
心肌梗死后CCL2介导的海马小胶质细胞极化失衡在认知功能障碍中的作用机制研究
  • 批准号:
    2026JJ81895
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    申婷
  • 依托单位:
CCL2/CCR2介导DRG“单核巨噬细胞-痛觉 神经元 ”交互作用调控疱疹神经痛发生 的机制研究
Ccl2高表达肿瘤细胞通过非免疫途径调控结直肠癌进展的机制研究